Interests: Cell fate decisions and epigenetic buffering; tissue specific DNA architecture based vulnerabilities to cancer

Eli joined the lab in 2020 and is currently studying the role of mitochondrial MDM2 in liposarcoma, both from a wet lab and computational perspective.